MikeyNJ
$OM Axios reporting that HHS is calling for changes in the dialysis market which is dominated by DaVita and Fresenius. The plan is to reduce government overreach, promoting accountability, competition, and innovation. It blames consolidation in the market where the two companies constitute 74% of the market where they leverage market power into higher prices.
This is a big positive for Onset Medical.
8
